Clinical Trial: Correlation Between Gut Microbiota and the Clinical Efficacy of Immune Checkpoint Inhibitors Combined With Anti-angiogenic Targeted Therapy in Renal Cancer: A Prospective, Single-center, Observational Study (China)

Posted On: 2026-09-08

China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Correlation Between Gut Microbiota and the Clinical Efficacy of Immune Checkpoint Inhibitors Combined With Anti-angiogenic Targeted Therapy in Renal Cancer: A Prospective, Single-center, Observational Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131801

Registration Time: 2026/09/07

Type: Observational study

Primary Sponsor: Shanghai Changhai Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=281393

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Correlation Between Gut Microbiota and the Clinical Efficacy of Immune Checkpoint Inhibitors Combined With Anti-angiogenic Targeted Therapy in Renal Cancer: A Prospective, Single-center, Observational Study (China)